KRAS and neoplasm: A complete characterization of the paracrine effects of K-Ras-mutant cancer cells in models with mutant K-Ras would be valuable to obtain an overall view of these effects, identify tumor specificities, and point to possible combination therapies with stromal modulatory approaches.